We are a specialty pharmaceutical company focused on the development and commercialization of therapeutic product candidates that address the limitations of market-leading products in certain orphan and other well-defined, high-margin specialty markets.
|Aug31||SteadyMed Receives Refusal to File Letter from FDA for Trevyent® New Drug Application|
|Aug11||SteadyMed Reports Second Quarter 2017 Financial Results and Provides Corporate Update|
|Aug09||SteadyMed to Present at the 2017 Wedbush PacGrow Healthcare Conference|
SteadyMed and the Pulmonary Hypertension Association (PHA) California Chapter launched the PHenomenal campaign, asking people with pulmonary arterial hypertension (PAH) and other forms of pulmonary hypertension (PH), along with their loved ones, to submit photos and videos showing how they refuse to let the disease define their lives. Submissions should be tagged with #PHenomSelf on Tumblr, Instagram, Facebook and Twitter. People can also learn more about the campaign and see others’ submissions on our Tumblr (www.tumblr.com/blog/phenomself) and Instagram (www.instagram.com/phenomself") pages. Together let’s celebrate the unique and inspiring faces behind PAH and PH!